Geode Capital Management, LLC Nanobiotix S.A. Transaction History
Geode Capital Management, LLC
- $1.26 Trillion
- Q4 2024
A detailed history of Geode Capital Management, LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Geode Capital Management, LLC holds 10,184 shares of NBTX stock, worth $37,578. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,184Holding current value
$37,578% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NBTX
# of Institutions
19Shares Held
6.25MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$20.8 Million5.5% of portfolio
-
Perceptive Advisors LLC New York, NY266KShares$981,8830.03% of portfolio
-
Black Rock Inc. New York, NY239KShares$881,9390.0% of portfolio
-
Old Mission Capital LLC48.5KShares$178,8690.0% of portfolio
-
Jane Street Group, LLC New York, NY23.3KShares$85,9140.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $129M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...